Long-term survival of stage IV melanoma patients treated with a polyvalent, shed antigen, melanoma vaccine

被引：0
|
作者：
Laky, D
Shapiro, RL
Harris, MN
Roses, DF
Jacquotte, AZ
Reynolds, SR
Bystryn, J
机构：
[1] NYU, Sch Med, Kaplan Comprehens Canc Ctr, New York, NY USA
[2] NYU, Sch Med, Dept Surg, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2002年 / 119卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
198
引用
收藏
页码：240 / 240
页数：1
相关论文
共 50 条
  • [1] Long-term survival of stage IV melanoma patients: evaluation on 640 melanoma patients entering stage IV between 2014 and 2017
    Reitmajer, Markus
    Leiter, Ulrike
    Nanz, Lena
    Amaral, Teresa
    Flatz, Lukas
    Garbe, Claus
    Forschner, Andrea
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (01)
  • [2] Predictors of long-term survival in stage IV malignant melanoma (MM) patients
    Bafaloukos, D
    Fountzilas, G
    Semoglou, C
    Vasilaki, V
    Kosmidis, P
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1166 - 1166
  • [3] Randomized, double-blind phase III trial of a polyvalent, shed, melanoma antigen vaccine in stage III melanoma
    Bystryn, JC
    Oratz, R
    Shapiro, RL
    Harris, MN
    Roses, DF
    Jacquotte, A
    Chen, DL
    Rivas, M
    ANNALS OF ONCOLOGY, 1998, 9 : 84 - 84
  • [4] IMMUNOGENICITY OF A POLYVALENT MELANOMA ANTIGEN VACCINE IN PATIENTS WITH EARLY MELANOMA
    BYSTRYN, JC
    LONBERG, M
    BERNSTEIN, P
    HARRIS, M
    ROSES, D
    SPEYER, J
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1985, 26 (MAR): : 312 - 312
  • [5] TREATMENT OF MELANOMA WITH A POLYVALENT MELANOMA ANTIGEN VACCINE
    BYSTRYN, JC
    JOURNAL OF DERMATOLOGIC SURGERY AND ONCOLOGY, 1985, 11 (08): : 775 - 776
  • [6] POLYVALENT MELANOMA VACCINE IMPROVES SURVIVAL OF PATIENTS WITH METASTATIC MELANOMA
    MORTON, DL
    HOON, DSB
    NIZZE, JA
    FOSHAG, LJ
    FAMATIGA, E
    WANEK, LA
    CHANG, C
    IRIE, RF
    GUPTA, RK
    ELASHOFF, R
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 690 : 120 - 134
  • [7] Disease-free long-term survival in stage IV melanoma
    Schwabe, M.
    ONKOLOGIE, 2011, 34 : 294 - 294
  • [8] Double-blind trial of a polyvalent, shed-antigen, melanoma vaccine
    Bystryn, JC
    Zeleniuch-Jacquotte, A
    Oratz, R
    Shapiro, RL
    Harris, MN
    Roses, DF
    CLINICAL CANCER RESEARCH, 2001, 7 (07) : 1882 - 1887
  • [9] Is the survival of melanoma patients receiving polyvalent melanoma cell vaccine linked to the human leukocyte antigen phenotype of patients?
    Hoon, DSB
    Okamoto, T
    Wang, HJ
    Elashoff, R
    Nizze, AJ
    Foshag, LJ
    Gammon, G
    Morton, DL
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (04) : 1430 - 1437
  • [10] Long-term survival in stage IV melanoma after repetitive surgical therapy
    Tomov, Tsvetomir
    Siegel, Robert
    Bembenek, Andreas
    ONKOLOGIE, 2008, 31 (05): : 259 - 261
12345